OmniAb OABI
NASDAQ OABI
$4.87 -0.12 (-2.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

OmniAb (OABI) Long-Term Investments (2021 - 2022)

Updated

OmniAb's Long-Term Investments came in at $237.19 million for Q3 2022, up 0.6% from $235.75 million a year earlier and up 0.5% from the prior quarter.

Analysis

OmniAb (OABI) Long-Term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, OmniAb's Long-Term Investments was $235.75 million.

  • Business Quant data shows OABI's Long-Term Investments at $236.1 million (Q2 2022), $235.8 million (Q1 2022) and $235.75 million (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 OmniAb 725.50 Mn 510.91 Mn 12.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 237.19 Mn
Jun 30, 2022 236.10 Mn
Mar 31, 2022 235.80 Mn
Dec 31, 2021 235.75 Mn
Sep 30, 2021 235.75 Mn
API Access

OmniAb Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=OABI&period=max&api_key=YOUR_API_KEY